Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vasodilatory effects of cannabidiol in human pulmonary and rat small mesenteric arteries: modification by hypertension and the potential pharmacological opportunities
Marta Baranowska‐Kuczko, Hanna Kozłowska, Monika Kloza, et al.
Journal of Hypertension (2019) Vol. 38, Iss. 5, pp. 896-911
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

The Effects of Cannabidiol, a Non-Intoxicating Compound of Cannabis, on the Cardiovascular System in Health and Disease
Aleksandra Kicman, Marek Toczek
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6740-6740
Open Access | Times Cited: 105
Cannabidiol goes nuclear: The role of PPARγ
Sara Khosropoor, Mohaddeseh Sadat Alavi, Leila Etemad, et al.
Phytomedicine (2023) Vol. 114, pp. 154771-154771
Closed Access | Times Cited: 29
Chronic Cannabidiol Administration Fails to Diminish Blood Pressure in Rats with Primary and Secondary Hypertension Despite Its Effects on Cardiac and Plasma Endocannabinoid System, Oxidative Stress and Lipid Metabolism
Patryk Remiszewski, Iwona Jarocka-Karpowicz, Michał Biernacki, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 4, pp. 1295-1295
Open Access | Times Cited: 54
Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19
Barbara Malinowska, Marta Baranowska‐Kuczko, Aleksandra Kicman, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1986-1986
Open Access | Times Cited: 46
Cannabidiol attenuates pulmonary arterial hypertension by improving vascular smooth muscle cells mitochondrial function
Xiaohui Lü, Jingyuan Zhang, Huijiao Liu, et al.
Theranostics (2021) Vol. 11, Iss. 11, pp. 5267-5278
Open Access | Times Cited: 44
Molecular and Biochemical Mechanism of Cannabidiol in the Management of the Inflammatory and Oxidative Processes Associated with Endometriosis
Tiziana Genovese, Marika Cordaro, Rosalba Siracusa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5427-5427
Open Access | Times Cited: 31
A single dose of cannabidiol (CBD) positively influences measures of stress in dogs during separation and car travel
Alysia B. G. Hunt, Hannah E. Flint, Darren W. Logan, et al.
Frontiers in Veterinary Science (2023) Vol. 10
Open Access | Times Cited: 20
Resolvin D2 and its receptor GPR18 in cardiovascular and metabolic diseases: A promising biomarker and therapeutic target
Mengmeng Zhao, Zihui Zheng, Zheng Yin, et al.
Pharmacological Research (2023) Vol. 195, pp. 106832-106832
Open Access | Times Cited: 18
CBD supplementation reduces arterial blood pressure via modulation of the sympatho-chromaffin system: A substudy from the HYPER-H21-4 trial
Marko Kumrić, Goran Dujić, Josip Vrdoljak, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114387-114387
Open Access | Times Cited: 14
Cannabidiol Toxicity Driven by Hydroxyquinone Formation
Montenegro Montero, Pravien S. Rajaram, Jose E. Zamora Alvarado, et al.
Chemical Research in Toxicology (2025)
Open Access
Cannabidiol Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats
Olga Sadowska, Marta Baranowska‐Kuczko, Anna Gromotowicz-Popławska, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7077-7077
Open Access | Times Cited: 34
Cannabidiol Improves Antioxidant Capacity and Reduces Inflammation in the Lungs of Rats with Monocrotaline-Induced Pulmonary Hypertension
Anna Krzyżewska, Marta Baranowska‐Kuczko, Anna Jastrząb, et al.
Molecules (2022) Vol. 27, Iss. 10, pp. 3327-3327
Open Access | Times Cited: 20
Cannabidiol protects against acute aortic dissection by inhibiting macrophage infiltration and PMAIP1-induced vascular smooth muscle cell apoptosis
Yilong Guo, Yang Che, Xuelin Zhang, et al.
Journal of Molecular and Cellular Cardiology (2024) Vol. 189, pp. 38-51
Open Access | Times Cited: 4
Comprehensive mini-review: therapeutic potential of cannabigerol – focus on the cardiovascular system
Anna Krzyżewska, Monika Kloza, Hanna Kozłowska
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Cannabidiol alleviates right ventricular fibrosis by inhibiting the transforming growth factor β pathway in monocrotaline-induced pulmonary hypertension in rats
Anna Krzyżewska, Marta Baranowska‐Kuczko, Irena Kasacka, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 6, pp. 166753-166753
Open Access | Times Cited: 10
The role of cannabidiol in aging
Beibei Ni, Yanying Liu, Meng Dai, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115074-115074
Open Access | Times Cited: 10
Therapeutic potential of cannabidiol (CBD) in the treatment of cardiovascular diseases
Nadia Martínez Naya, Jazmin Kelly, Austin C. Hogwood, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 7, pp. 699-712
Closed Access | Times Cited: 3
Mechanosensitivity in Pulmonary Circulation: Pathophysiological Relevance of Stretch-Activated Channels in Pulmonary Hypertension
Solène Barbeau, Guillaume Gilbert, Guillaume Cardouat, et al.
Biomolecules (2021) Vol. 11, Iss. 9, pp. 1389-1389
Open Access | Times Cited: 22
How do phytocannabinoids affect cardiovascular health? An update on the most common cardiovascular diseases
Sylwia Dziemitko, Ewa Harasim‐Symbor, Adrian Chabowski
Therapeutic Advances in Chronic Disease (2023) Vol. 14
Open Access | Times Cited: 8
Vasoprotective Endothelial Effects of Chronic Cannabidiol Treatment and Its Influence on the Endocannabinoid System in Rats with Primary and Secondary Hypertension
Marta Baranowska‐Kuczko, Hanna Kozłowska, Monika Kloza, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 11, pp. 1120-1120
Open Access | Times Cited: 16
Acute Cannabigerol Administration Lowers Blood Pressure in Mice
Victoria Vernail, Sarah S. Bingaman, Yuval Silberman, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 11
Chronic Effects of Oral Cannabidiol Delivery on 24-h Ambulatory Blood Pressure in Patients with Hypertension (HYPER-H21-4): A Randomized, Placebo-Controlled, and Crossover Study
Goran Dujić, Marko Kumrić, Josip Vrdoljak, et al.
Cannabis and Cannabinoid Research (2023) Vol. 9, Iss. 4, pp. 979-989
Closed Access | Times Cited: 6
Naturally Occurring Cannabinoids and their Role in Modulation of Cardiovascular Health
Elnaz Karimian Azari, Aileen Kerrigan, Annalouise O’Connor
Journal of Dietary Supplements (2020) Vol. 17, Iss. 5, pp. 625-650
Open Access | Times Cited: 16
Transient receptor potential vanilloid (TRPV) channels: Basal properties and physiological potential
Tomohiko Sasase, Fatchiyah Fatchiyah, T. Ohta
General Physiology and Biophysics (2022) Vol. 41, Iss. 03, pp. 165-190
Open Access | Times Cited: 10
The Influence of Oral Cannabidiol on 24-h Ambulatory Blood Pressure and Arterial Stiffness in Untreated Hypertension: A Double-Blind, Placebo-Controlled, Cross-Over Pilot Study
Tanja Dragun, Courtney V. Brown, Mikko P. Tulppo, et al.
Advances in Therapy (2023) Vol. 40, Iss. 8, pp. 3495-3511
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top